PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Commodore Capital LP's Holding History (CIK: 0001831942)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 450,000 Value ($000) $39,303 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 1,025,000 Value ($000) $68,091 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 1,075,000 Value ($000) $59,415 Avg Close $47.99 Range $39.60 - $57.70
Q1 2022
Shares 331,886 Value ($000) $7,859 Avg Close $28.17 Range $22.56 - $37.05
Q4 2021
Shares 805,573 Value ($000) $27,551 Avg Close $31.61 Range $17.26 - $38.11
Q3 2021
Shares 498,079 Value ($000) $8,826 Avg Close $42.63 Range $12.80 - $50.54
Q2 2021
Shares 210,600 Value ($000) $9,452 Avg Close $33.01 Range $24.14 - $45.93
Q1 2021
Shares 349,600 Value ($000) $9,055 Avg Close $25.31 Range $18.82 - $32.10
Q4 2020
Shares 347,500 Value ($000) $7,006 Avg Close $21.52 Range $17.44 - $25.65